Jupiter Neurosciences, Inc. (JUNS)
2.20
+0.07
(+3.29%)
USD |
NASDAQ |
Nov 06, 16:00
2.01
-0.19
(-8.64%)
After-Hours: 20:00
Jupiter Neurosciences Gross Profit Margin (Quarterly) : 87.19% for June 30, 2026
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 87.19% |
| March 31, 2026 | 76.47% |
| Date | Value |
|---|---|
| December 31, 2025 | 80.73% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| Johnson & Johnson | 68.11% |
| ANI Pharmaceuticals, Inc. | 54.92% |
| Corcept Therapeutics, Inc. | 98.65% |
| Veru, Inc. | -- |
| Eli Lilly & Co. | 83.88% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Assets | -232.6% |
| Return on Invested Capital | -525.6% |
| Profit Margin (Quarterly) | -9.40K% |
| Operating Margin (Quarterly) | -11.33K% |
| Return on Net Operating Assets | -994.4% |